Compare BioNano Genomics Inc (BNGO) vs Abrdn Physical Platinum Shares ETF (PPLT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Abrdn Physical Platinum Shares ETF — how do they compare? BioNano Genomics Inc trades at $1.17 (market cap $13.66M), while Abrdn Physical Platinum Shares ETF trades at $16.1. The key difference: Abrdn Physical Platinum Shares ETF is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | PPLT | |
|---|---|---|
Market Cap | $13.66M | — |
Sector | Health | Commodities - Metals/Agriculture |
52-Week High | $4.92 | $25.23 |
52-Week Low | $1.06 | $11.95 |
Enterprise Value | $16.26M | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.16 with a bullish technical signal supported by moving averages. The company shows improving financial trends with narrowing losses and consistent earnings beats, though it remains unprofitable with negative margins. Recent news highlights operational progress including debt retirement and scientific publications. Valuation ratios appear attractive with P/S of 0.31 and P/B of 0.36.
The outlook remains speculative given persistent losses, but improving cash flow trends and analyst optimism provide catalysts. Key risks include ongoing negative profitability and competitive pressures in genomics. With 57% analyst buy ratings and bullish technical momentum, the stock offers high-risk growth potential for investors comfortable with biotech volatility.
PPLT (abrdn Platinum ETF Trust) trades at $16.12, up 1.32% with a bullish technical signal supported by moving averages. The ETF focuses on physical platinum exposure, benefiting from recent precious metals momentum. Recent news highlights platinum's underperformance relative to gold and silver, suggesting potential catch-up trade opportunities. A 1:10 stock split is scheduled for May 2026 to enhance accessibility.
The outlook remains positive as platinum's valuation gap versus other precious metals presents upside potential. Key risks include commodity price volatility and macroeconomic sensitivity. With zero dividend payments, the investment case relies solely on price appreciation and platinum's industrial and investment demand dynamics.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Abrdn Physical Platinum Shares ETF
PPLT is a physically-backed ETF designed to track the spot price of platinum, less the Trust's expenses. It holds physical platinum bullion in secure vaults, providing investors with a liquid and cost-effective way to access the platinum market without the logistical challenges of direct ownership.
Read more on PPLT →
